Parabilis Medicines, Inc. (PBLS)

40.10 +0.63 (+1.60%) USD  |  NASDAQ  |  Sep 02, 16:00
40.07 -0.03 (-0.07%) After-Hours: 18:37
More

Parabilis Medicines Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for PBLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Operating Income (Annual) Data

View and export this data back to 2024. Start Trial.
Date Value
December 31, 2025 --
Date Value
December 31, 2024 --

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
Moderna, Inc. Upgrade
Kailera Therapeutics, Inc. Upgrade
Arrowhead Pharmaceuticals, Inc. Upgrade
Oncolytics Biotech, Inc. Upgrade
Sangamo Therapeutics, Inc. Upgrade